Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05447559 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study

Study acronym: CALIPSO
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jan 2027 to Dec 2027 Study sites: 22 to 27 · Completion date: Jun 2027 to Jun 2028 · Collaborator revisedv5 Show 3 more changesShow less
    • Study sites: 22 to 27
    • Completion date: Jun 2027 to Jun 2028
    • Collaborator revised

    See this version in full on ClinicalTrials.gov ↗

  2. Study sites: 19 to 22 Collaborator revisedv4 Show 1 more changeShow less
    • Collaborator revised

    See this version in full on ClinicalTrials.gov ↗

  3. Enrollment target: 9000 to 9180 Study sites: 8 to 19v3 Show 1 more changeShow less
    • Study sites: 8 to 19
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Sep 1, 2022 to Feb 7, 2023 · Study sites: 0 to 8v2 Show 2 more changesShow less
    • Start date changed from estimate of Sep 1, 2022 to Feb 7, 2023
    • Study sites: 0 to 8
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This multicentre, adaptive, pragmatic, double-blind, three-arm, placebo-controlled, randomised, non-inferiority clinical trial will compare the incidence of surgical site infection and other healthcare associated infections, health economic and microbiological impact after intraoperative only (Arm A), to 24 hours (Arm B) and, to 48 hours (Arm C) of IV cefazolin and placebo postoperative surgical antimicrobial prophylaxis in patients undergoing cardiac surgery
Trial Details
NCT Number NCT05447559
Lead Sponsor Monash University
Collaborators: ANZCA CTN
Conditions Surgical Site Infection
Enrollment 9,180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov